Skip to main content
Year archive

ALTERITY THERAPEUTICS LIMITED — 2021 filings

All 107 regulatory filings released by ALTERITY THERAPEUTICS LIMITED (ATH) in 2021, sourced directly from the official regulator.

107 Filings
2021 Period
2021 filings (107)
Filing Released Lang
Change in substantial holding 5 pages 908.0KB
Major Shareholding Notification
2021-12-21 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings
2021-12-15 English
Notification of cessation of securities - ATH 4 pages 24.3KB
Share Issue/Capital Change
2021-12-14 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings
2021-12-14 English
First Regulatory Authorization to Proceed with Phase 2 Trial 3 pages 259.8KB
Regulatory Filings
2021-12-13 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings
2021-12-09 English
Notification regarding unquoted securities - ATH 9 pages 37.2KB
Share Issue/Capital Change
2021-12-08 English
Change in substantial holding 5 pages 844.6KB
Major Shareholding Notification
2021-12-05 English
Change in substantial holding 5 pages 865.6KB
Major Shareholding Notification
2021-11-23 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings
2021-11-22 English
Alterity to present at upcoming investor conferences 1
Regulatory Filings
2021-11-21 English
REPORT OF FOREIGN PRIVATE ISSUER
AGM Information
2021-11-12 English
REPORT OF FOREIGN PRIVATE ISSUER
AGM Information
2021-11-12 English
REPORT OF FOREIGN PRIVATE ISSUER
AGM Information
2021-11-12 English
Chairman's Address 2021 Annual General Meeting 3 pages 207.5KB
AGM Information
2021-11-11 English
ATH Annual General Meeting Presentation 32 pages 3.6MB
Regulatory Filings
2021-11-11 English
Results of Annual General Meeting 2 pages 190.7KB
Declaration of Voting Results & Voting Rights Announcements
2021-11-11 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings
2021-11-09 English
Alterity presents at American Autonomic Society Meeting 3 pages 281.5KB
Regulatory Filings
2021-11-08 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings
2021-11-04 English
New Data Advance ATH434 as Neurodegeneration treatment 4 pages 271.0KB
Regulatory Filings
2021-11-03 English
Change in substantial holding 5 pages 908.1KB
Major Shareholding Notification
2021-11-02 English
REPORT OF FOREIGN PRIVATE ISSUER
Interim / Quarterly Report Q1 2022
2021-10-29 English
Appendix 4C and Quarterly Cash Flow Report 8 pages 1.9MB
Interim / Quarterly Report Q1 2022
2021-10-28 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings
2021-10-19 English
Expanded ATH434 Phase 2 Clinical Development Program 3 pages 281.0KB
Regulatory Filings
2021-10-18 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings
2021-10-12 English
Notice of Annual General Meeting/Proxy Form 19 pages 765.9KB
AGM Information
2021-10-10 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings
2021-09-20 English
Presentation of New Biomarker Data at Scientific Congress 3 pages 267.5KB
Regulatory Filings
2021-09-19 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings
2021-09-03 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings
2021-09-03 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings
2021-09-03 English
ATH filed Form 20-F and XBRL data with SEC 2 pages 209.1KB
Report Publication Announcement
2021-09-02 English
Form 20-F 139 pages 791.2KB
Annual Report FY 2021
2021-09-02 English
ANNUAL REPORT
Annual Report FY 2021
2021-09-02 English
Appendix 4E & Annual Report 2021 143 pages 2.9MB
Annual Report FY 2021
2021-08-31 English
Appendix 4G and Corporate Governance Statement 2021 21 pages 357.2KB
Governance Information
2021-08-31 English
Change in substantial holding 5 pages 1.9MB
Major Shareholding Notification
2021-08-31 English
Change in substantial holding 5 pages 909.5KB
Major Shareholding Notification
2021-08-11 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings
2021-08-04 English
New US Patent Expands Neurodegeneration Treatment Portfolio 2 pages 258.0KB
Regulatory Filings
2021-08-03 English
REPORT OF FOREIGN PRIVATE ISSUER
Interim / Quarterly Report Q4 2021
2021-07-30 English
Appendix 4C and Quarterly Cash Flow Report 8 pages 422.7KB
Interim / Quarterly Report Q4 2021
2021-07-29 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings
2021-07-15 English
New Publication Demonstrates ATH434 is Neuroprotective 3 pages 346.6KB
Regulatory Filings
2021-07-14 English
Change in substantial holding 5 pages 896.6KB
Major Shareholding Notification
2021-07-12 English
SC 13D/A
Major Shareholding Notification
2021-07-08 English
Change in substantial holding 5 pages 899.9KB
Major Shareholding Notification
2021-07-08 English
Change in substantial holding 3 pages 953.6KB
Regulatory Filings
2021-07-08 English
Change in substantial holding 5 pages 1.9MB
Major Shareholding Notification
2021-07-07 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings
2021-07-06 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings
2021-07-06 English
Change in substantial holding 5 pages 1.9MB
Major Shareholding Notification
2021-07-05 English
Application for quotation of securities - ATH 6 pages 27.7KB
Capital/Financing Update
2021-07-04 English
Notice under section 708A(5) of the Corporations Act 1
Capital/Financing Update
2021-07-04 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings
2021-07-02 English
Proposed issue of securities - ATH 5 pages 27.6KB
Capital/Financing Update
2021-07-01 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings
2021-07-01 English
New US patent targeting major neurodegenerative diseases 2 pages 240.1KB
Regulatory Filings
2021-06-30 English
Change in substantial holding 5 pages 905.9KB
Major Shareholding Notification
2021-06-29 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings
2021-06-23 English
EU Regulatory Guidance for ATH434 Phase 2 Clinical Trial 2 pages 218.6KB
Regulatory Filings
2021-06-22 English
REPORT OF FOREIGN PRIVATE ISSUER
Investor Presentation
2021-06-17 English
Investor Presentation 26 pages 2.1MB
Regulatory Filings
2021-06-16 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings
2021-06-16 English
Alterity to present at MST Access Investor Conference 2 pages 209.8KB
Investor Presentation
2021-06-15 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings
2021-04-29 English
Appendix 4C and Quarterly Cash Flow Report 7 pages 430.0KB
Interim / Quarterly Report Q3 2021
2021-04-28 English
Change in substantial holding 5 pages 1.9MB
Major Shareholding Notification
2021-04-27 English
Ceasing to be a substantial holder 2 pages 81.2KB
Major Shareholding Notification
2021-04-22 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings
2021-04-21 English
ATH434 protects brain cells and improves motor function 2 pages 220.6KB
Regulatory Filings
2021-04-20 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings
2021-04-20 English
Appendix 3G 12 pages 356.6KB
Capital/Financing Update
2021-04-19 English
Change in substantial holding 2 pages 84.7KB
Major Shareholding Notification
2021-03-14 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings
2021-03-10 English
Alterity to present at Global Life Science Conference 26 pages 1.8MB
Investor Presentation
2021-03-09 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings
2021-02-26 English
Alterity to present at 7th International Congress of MSA 2 pages 206.4KB
Regulatory Filings
2021-02-25 English
Change in substantial holding 2 pages 84.4KB
Major Shareholding Notification
2021-02-25 English
REPORT OF FOREIGN PRIVATE ISSUER
Interim / Quarterly Report H1 2021
2021-02-25 English
Half Yearly Report and Accounts 28 pages 383.5KB
Interim / Quarterly Report H1 2021
2021-02-24 English
Change in substantial holding 5 pages 1.9MB
Major Shareholding Notification
2021-02-21 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings
2021-02-19 English
Alterity Half Year Results and Investor Webcast Notification 2 pages 199.7KB
Report Publication Announcement
2021-02-18 English
Change in substantial holding 5 pages 896.4KB
Major Shareholding Notification
2021-02-15 English
Change in substantial holding 5 pages 1.9MB
Major Shareholding Notification
2021-02-14 English
Change in substantial holding 2 pages 83.2KB
Major Shareholding Notification
2021-02-14 English
Change in substantial holding 2 pages 82.6KB
Major Shareholding Notification
2021-02-11 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings
2021-02-11 English
Change in substantial holding 5 pages 904.3KB
Major Shareholding Notification
2021-02-10 English
Appendix 2A and Section 708A(5) Cleansing Notice 16 pages 389.0KB
Capital/Financing Update
2021-02-10 English
REPORT OF FOREIGN PRIVATE ISSUER
Capital/Financing Update
2021-02-10 English
Proposed issue of Securities - ATH 5 pages 27.3KB
Capital/Financing Update
2021-02-09 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings
2021-02-09 English
Michael J Fox grant for Parkinson's research on ATH434 3 pages 200.0KB
Capital/Financing Update
2021-02-08 English
REPORT OF FOREIGN PRIVATE ISSUER
Interim / Quarterly Report Q2 2021
2021-01-28 English
Appendix 4C and Quarterly Cash Flow Report 8 pages 348.0KB
Interim / Quarterly Report Q2 2021
2021-01-27 English
Change in substantial holding 2 pages 83.8KB
Major Shareholding Notification
2021-01-13 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings
2021-01-11 English
Alterity participates in JP Morgan healthcare conference 2 pages 207.5KB
Investor Presentation
2021-01-10 English
REPORT OF FOREIGN PRIVATE ISSUER
Board/Management Information
2021-01-07 English
Regulatory Filings 2021
Regulatory Filings
2021-01-07 English
PROSPECTUS
Capital/Financing Update
2021-01-06 English
Dr David Stamler Appointed CEO 3 pages 257.7KB
Board/Management Information
2021-01-06 English
Regulatory Filings 2021
Regulatory Filings
2021-01-04 English